期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 132, 期 -, 页码 270-295出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2018.07.016
关键词
Skin tissue engineering; Artificial skin; 3D bioprinting; Tissue engineering
资金
- A*STAR [APG2013/40A, R279-000-487-305, R261-509-001-646]
- National University of Singapore [APG2013/40A, R279-000-487-305, R261-509-001-646]
Bioprinted skin tissue has the potential for aiding drug screening, formulation development, clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations of conventional skin tissue engineering approaches have driven the development of biomimetic skin equivalent via 3D bioprinting. A key hope for bioprinting skin is the improved tissue authenticity over conventional skin equivalent construction, enabling the precise localization of multiple cell types and appendages within a construct. The printing of skin faces challenges broadly associated with general 3D bioprinting, including the selection of cell types and biomaterials, and additionally requires in vitro culture formats that allow for growth at an air-liquid interface. This paper provides a thorough review of current 3D bioprinting technologies used to engineer human skin constructs and presents the overall pipelines of designing a biomimetic artificial skin via 3D bioprinting from the design phase (i.e. pre-processing phase) through the tissue maturation phase (i.e. post-processing) and into final product evaluation for drug screening, development, and drug delivery applications. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据